Staffanstorp, Sweden

Inga-Maria Frick


Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2004-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inga-Maria Frick: Innovator in Antimicrobial Research

Introduction

Inga-Maria Frick is a notable inventor based in Staffanstorp, Sweden. She has made significant contributions to the field of antimicrobial research, holding a total of 3 patents. Her work focuses on enhancing the effectiveness of antimicrobial agents, which is crucial in the fight against infections.

Latest Patents

One of her latest patents involves a method of identifying an agent that enhances the antimicrobial activity of cationic antimicrobial peptides. This method includes several components, such as a cationic antimicrobial peptide, bacteria, and elements of the proteinase/glycosaminoglycan pathway. The goal is to determine whether a test agent can enhance the antimicrobial activity, which is particularly useful in treating acute and chronic infections, including ulcers and promoting wound healing. Another significant patent by Frick is a nuclear delivery construct that targets the nucleus of eukaryotic cells using bacterial proteins, showcasing her innovative approach to medical therapies.

Career Highlights

Inga-Maria Frick is associated with Hansa Medical AB, a company that focuses on developing innovative therapies. Her work has been instrumental in advancing the understanding of antimicrobial mechanisms and their applications in medicine.

Collaborations

Frick has collaborated with notable colleagues, including Tomas Borje Leandersson and Lars Bjorck. These partnerships have contributed to her research and the development of her patented technologies.

Conclusion

Inga-Maria Frick is a pioneering inventor whose work in antimicrobial research has the potential to significantly impact medical treatments. Her innovative patents and collaborations highlight her dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…